Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey

다국어 초록 (Multilingual Abstract)

Background: Several studies in Western populations have indicated that metabolic syndrome (MetS) is inferior to the Framingham risk score (FRS) in predicting coronary heart disease (CHD). However there has been no study about the predictability of MetS vs. FRS for CHD in Korea.
Methods: Among the 43,145 persons from the third Korea National Health and Nutrition Examination Survey in 2005, laboratory test and nutritional survey data from 5,271 persons were examined. Participants were also asked to recall a physician’s diagnosis of CHD.
Results: The median age was 46 (range, 20 to 78) in men (n=2,257) and 44 (range, 20 to 78) years in women (n=3,014). Prevalence of self-reported CHD was 1.7% in men and 2.1% in women. Receiver operating characteristic curves and their respective area under the curve (AUC) were used to compare the ability of the FRS and the number of components of MetS to predict self-reported CHD in each sex. In men, AUC of FRS was significantly larger than that of MetS (0.767 [0.708 to 0.819] vs. 0.677 [0.541 to 0.713], P<0.01). In women, AUC of FRS was comparable to that of MetS (0.777 [0.728 to 0.826] vs. 0.733 [0.673 to 0.795]), and was not significant.
Conclusion: The data suggested that FRS was more closely associated with CHD compared to MetS in Korean men.

참고문헌 (Reference)

1 Woodward M, "The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease" 16 : 210-214, 2009

2 Lakka HM, "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men" 288 : 2709-2716, 2002

3 Girman CJ, "The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)" 93 : 136-141, 2004

4 Ford ES, "The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study" 173 : 309-314, 2004

5 McNeill AM, "The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study" 28 : 385-390, 2005

6 Eckel RH, "The metabolic syndrome" 365 : 1415-1428, 2005

7 Ministry for Health, Welfare and Family Affairs, "The Third Korea National Health and Nutrition Examination Survey (KNHANES III)"

8 Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial" 288 : 321-333, 2002

9 Zweig MH, "Receiver-operating characteristic(ROC) plots: a fundamental evaluation tool in clinical medicine" 39 : 561-577, 1993

10 Hulley S, "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group" 280 : 605-613, 1998

11 Hu G, "Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women" 164 : 1066-1076, 2004

12 Brindle P, "Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study" 327 : 1267-, 2003

13 Hunt KJ, "National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study" 110 : 1251-1257, 2004

14 Onat A, "Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: a prospective and cross-sectional evaluation" 165 : 285-292, 2002

15 Meigs JB, "Metabolic syndrome: in search of a clinical role" 27 : 2761-2763, 2004

16 Sattar N, "Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study" 108 : 414-419, 2003

17 Wannamethee SG, "Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus" 165 : 2644-2650, 2005

18 Gami AS, "Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta- analysis of longitudinal studies" 49 : 403-414, 2007

19 De Flines J, "Management of metabolic syndrome and associated cardiovascular risk factors" 73 : 261-266, 2010

20 Resnick HE, "Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study" 26 : 861-867, 2003

21 Malik S, "Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults" 110 : 1245-1250, 2004

22 Alberti KG, "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity" 120 : 1640-1645, 2009

23 Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)" 285 : 2486-2497, 2001

24 Beavers KM, "Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome" 3 : 168-177, 2011

25 Stern MP, "Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?" 27 : 2676-2681, 2004

26 Grundy SM, "Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition" 109 : 433-438, 2004

27 Bonora E, "Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study" 26 : 1251-1257, 2003

28 Isomaa B, "Cardiovascular morbidity and mortality associated with the metabolic syndrome" 24 : 683-689, 2001

29 Ridker PM, "C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women" 107 : 391-397, 2003

30 Rutter MK, "C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study" 110 : 380-385, 2004

31 Anderson KM, "An updated coronary risk profile. A statement for health professionals" 83 : 356-362, 1991

32 Tota-Maharaj R, "A practical approach to the metabolic syndrome: review of current concepts and management" 25 : 502-512, 2010